The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Temozolomide versus irinotecan-temozolomide for children with relapsed and refractory high risk neuroblastoma (RR-HRNB): Results of the BEACON-Neuroblastoma randomized phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC) - International Society of Pediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.
 
Lucas Moreno
Honoraria - Celgene; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Mundipharma; Novartis; Roche
Research Funding - Abbvie (Inst); Aimmune (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Biosearch (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Novimmune (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst)
Patents, Royalties, Other Intellectual Property - Member of SIOPEN Executive Committee, SIOPEN receives royalties for the sales of dinutuximab beta (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Mundipharma
 
Veronica Moroz
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Jennifer Laidler
No Relationships to Disclose
 
Dominique Valteau-Couanet
Consulting or Advisory Role - EUSA Pharma (Inst)
Research Funding - Orphelia Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Apeiron to SIOPEN (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals
 
Marion Gambart
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Natasha Van Eijkelenburg
No Relationships to Disclose
 
Aurora Castellano
No Relationships to Disclose
 
Karsten Nysom
Consulting or Advisory Role - Bayer
 
Nicolas U. Gerber
Research Funding - Abbvie (Inst); Loxo (Inst); Novartis (Inst)
 
Genevieve Laureys
No Relationships to Disclose
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma
 
Guy Makin
No Relationships to Disclose
 
Sucheta Vaidya
No Relationships to Disclose
 
Estelle Thebaud
No Relationships to Disclose
 
Pamela Kearns
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim (Inst); Janssen (Inst)
 
Andrew DJ Pearson
Consulting or Advisory Role - Celgene; Lilly; Merck; Novartis; Takeda
Travel, Accommodations, Expenses - Celgene; Lilly; Merck; Novartis; Takeda
 
Keith Wheatley
No Relationships to Disclose